missing translation for 'onlineSavingsMsg'
Learn More

HTF9C Rabbit anti-Human, Clone: 2U3W8, Novus Biologicals™

Rabbit Monoclonal Antibody

£150.00 - £386.00

Specifications

Antigen HTF9C
Clone 2U3W8
Applications Western Blot
Classification Monoclonal
Conjugate Unconjugated
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18378255
View Documents
Novus Biologicals
NBP3-15244-20UL
20 μg
£150.00
20µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
18387104
View Documents
Novus Biologicals
NBP3-15244-100UL
100 μg
£386.00
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

HTF9C Monoclonal antibody specifically detects HTF9C in Human samples. It is validated for Western Blot
Specifications

Specifications

HTF9C
Western Blot
Unconjugated
Rabbit
Cancer
PBS, 0.05% BSA, 50% glycerol, pH7.3
27037
IgG
Affinity purified
2U3W8
Monoclonal
Purified
RUO
Human
HTF9CHpaII tiny fragments locus 9c protein, MGC102728, TRM2 tRNA methyltransferase 2 homolog A (S. cerevisiae), tRNA (uracil-5-)-methyltransferase homolog A, tRNA methyltransferase 2 homolog A
A synthetic peptide corresponding to a sequence within amino acids 1-100 of human HTF9C (Q8IZ69).
Primary
Store at -20°C. Avoid freeze-thaw cycles.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.